J. P. Soulillou, D. Cantarovich, L. Mauff, and B. , Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts, N Engl J Med, vol.322, pp.1175-1182, 1990.

B. Nashan, R. Moore, and P. Amlot, Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients, CHIB 201 International Study Group. Lancet, vol.350, pp.1193-1198, 1997.

J. P. Soulillou, M. A. Peyrat, and J. Guenel, Association between treatmentresistant kidney-allograft rejection and post-transplant appearance of antibodies to donor B-lymphocyte alloantigens, Lancet, vol.1, pp.354-356, 1978.

. Dantal-j, J. P. Soulillou, and B. Dreno, Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens, Lancet, vol.351, pp.623-628, 1998.

J. Dantal, M. Hourmant, and D. Cantarovich, Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens, Lancet, vol.351, pp.623-631, 1998.

M. Giral, J. M. Nguyen, and G. Karam, Impact of graft mass on the clinical outcome of kidney transplants, J Am Soc Nephrol, vol.16, pp.261-269, 2005.

J. Dantal, E. Bigot, and W. Bogers, Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome, N Engl J Med, vol.330, pp.7-14, 1994.

L. Berre, L. Godfrin, Y. Günther, and E. , Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats, J Clin Invest, vol.109, pp.491-499, 2002.

H. L. Mai, F. Boeffard, and J. Longis, IL-7 receptor blockade following T cell depletion promotes long-term allograft survival, J Clin Invest, vol.124, pp.1723-1756, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02167811

S. Brouard, E. Mansfield, and C. Braud, Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance, Proc Natl Acad Sci, vol.104, pp.15448-53, 2007.

S. Louis, C. Braudeau, and M. Giral, Contrasting CD25hiCD4 + T cells/ FOXP3 patterns in chronic rejection and operational drug-free tolerance, Transplantation, vol.81, pp.398-407, 2006.

M. Chesneau, L. Michel, and E. Dugast, Tolerant kidney transplant patients produce B cells with regulatory properties, J Am Soc Nephrol, vol.26, pp.2588-98, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02148982

J. P. Soulillou, C. B. Carpenter, and A. J. Apice, The role of nonclassical Fc receptor-associated, Ag-B antigens (Ia) in rat allograft enhancement, J Exp Med, vol.143, pp.405-426, 1976.

J. P. Soulillou, M. A. Peyrat, and J. Guenel, Association between treatmentresistant kidney-allograft rejection and post-transplant appearance of antibodies to donor B-lymphocyte alloantigens, Lancet, vol.1, pp.354-360, 1978.

H. Gascan, A. Godard, and C. Ferenz, Characterization and NH2-terminal amino acid sequence of natural human interleukin for DA cells: leukemia inhibitory factor. Differentiation inhibitory activity secreted by a T lymphoma cell line, J Biol Chem, vol.264, pp.21509-21524, 1989.

J. F. Moreau, M. Bonneville, and M. A. Peyrat, T lymphocyte cloning from rejected human kidney allografts. Growth frequency and functional/ phenotypic analysis, J Clin Invest, vol.78, pp.874-883, 1986.

J. P. Soulillou, D. Cantarovich, L. Mauff, and B. , Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts, N Engl J Med, vol.322, pp.1175-82, 1990.

B. Vanhove, G. Laflamme, and F. Coulon, Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody, Blood, vol.102, pp.564-70, 2003.